UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 15, 2010
Kinetic Concepts, Inc.
(Exact name of registrant as specified in its charter)
|
Texas
|
0001-09913
|
74-1891727
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
8023 Vantage Drive
San Antonio, Texas
|
78230
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (210) 524-9000
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On April 15, 2010, Dr. Todd M. Fruchterman, Executive Vice President, Research, Development & Clinical Sciences, Chief Technology Officer and Chief Medical Officer of Kinetic Concepts, Inc., resigned to pursue other opportunities.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
KINETIC CONCEPTS, INC.
(REGISTRANT)
|
|||
|
Date: April 21, 2010
|
By:
|
/s/ Martin J. Landon
|
|
|
Name:
|
Martin J. Landon
|
||
|
Title:
|
Executive Vice President and Chief Financial Officer
|
||
3